Crossmark Global Holdings, Inc. Lantheus Holdings, Inc. Transaction History
Crossmark Global Holdings, Inc.
- $6.02 Billion
- Q2 2025
A detailed history of Crossmark Global Holdings, Inc. transactions in Lantheus Holdings, Inc. stock. As of the latest transaction made, Crossmark Global Holdings, Inc. holds 4,710 shares of LNTH stock, worth $253,539. This represents 0.01% of its overall portfolio holdings.
Number of Shares
4,710
Previous 4,944
4.73%
Holding current value
$253,539
Previous $482,000
20.12%
% of portfolio
0.01%
Previous 0.01%
Shares
16 transactions
Others Institutions Holding LNTH
# of Institutions
542Shares Held
77.9MCall Options Held
710KPut Options Held
433K-
Black Rock Inc. New York, NY8.6MShares$463 Million0.02% of portfolio
-
Janus Henderson Group PLC London, X06.94MShares$374 Million0.29% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.84MShares$368 Million0.01% of portfolio
-
Farallon Capital Management LLC San Francisco, CA6.72MShares$362 Million2.47% of portfolio
-
State Street Corp Boston, MA2.56MShares$138 Million0.01% of portfolio
About Lantheus Holdings, Inc.
- Ticker LNTH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 68,741,904
- Market Cap $3.7B
- Description
- Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...